Objectives: To describe the baseline characteristics and management of patients with and without diabetes mellitus (DM) hospitalized with acute myocardial infarction (AMI) and to assess the influence of DM on hospital outcomes and hospital mortality. Subjects and Methods: We analyzed data from a 6-month observational study (Kuwait Acute Coronary Syndrome Registry) of unselected patients admitted with a diagnosis of AMI over a period of 6 months, from December 2003 through May 2004. Results: Of 1,295 patients enrolled, 609 (47%) were diabetics and 686 (53%) were non-diabetics. Diabetics were more likely to have a past history of coronary artery disease, hypertension and left ventricular systolic dysfunction than non-diabetics. There was less use of β-blockers and aspirin in diabetics as compared to non-diabetics (62 vs. 71% and 95.5 vs. 97.9%, p < 0.03, for β-blockers and aspirin, respectively). Left ventricular failure and cardiogenic shock occurred more often in diabetics compared to non-diabetics (16 vs. 7% and 5 vs. 3%, p < 0.001, for left ventricular failure and shock, respectively). The mortality rate was 6% for diabetics and 2% for non-diabetics (p < 0.001). Conclusion: DM is a major health problem among the adult population in Kuwait, and almost half the AMI population suffer from diabetes. Diabetic patients had higher rates of complications, especially left ventricular failure and cardiogenic shock, as compared to non-diabetic patients. The in-hospital mortality among diabetics with AMI was almost triple that of non-diabetics. The results of this study highlight the need to improve adherence to evidence-based treatment in diabetic patients with AMI.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.